Ustekinumab treatment in a patient with psoriasis and systemic lupus erythematosus

  • I-T Chyuan, T-H Tsai, T-H Chang, C-S Wu
  • Lupus, November 2014, SAGE Publications
  • DOI: 10.1177/0961203314561072

IL12/IL23 blockade in SLE: a case study

Why is it important?

There are unmet needs in the treatment of SLE. IL-23 blockade has some positive effects in the mice model of lupus nephritis.


Dr Chien-Sheng Wu
Far Eastern Memorial Hospital

SLE is used to be viewed as a B cell-mediated autoimmune disease. However, the success of rituximab in AAV in contrast to SLE implies that we have to rethink our hypothesis about the pathogenesis of SLE.

Read Publication

The following have contributed to this page: Dr Chien-Sheng Wu